. Accueil Recherche Carrière Actualités Services Contactez nous Eurofins France >> COVID-19 >> Actualités Actualités Eurofins Technologies launches total antibody (IgG, IgA and IgM) detection ELISA assays to aid the rapid identification of persons who have been exposed to SARS-CoV-2 (COVID-19) Eurofins Launches Eurofins SAFER@WORK™: a Comprehensive Suite of Risk-Based COVID-19 Safety Solutions for Businesses Eurofins Technologies launches multiplex Real-Time PCR assay for SARS-CoV-2 (coronavirus) pathogen detection Eurofins scientists develop multiple new solutions to support the world’s fight against the COVID-19 pandemic – ramping up production to enable over 20 million patients tests per month by end May 2020 Activity shows strong resilience in Q1 2020 Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response Eurofins BioPharma Product Testing delivers vital COVID-19 testing for all drug modalities and supply chains Eurofins Technologies launches multiple CE-IVD marked serologic products for the detection of antibodies in patients who have been exposed to SARS-CoV-2 (COVID-19) Eurofins Genomics launches “SARS-CoV-2 Full-length Genome Sequencing” service to support researchers globally in their fight against the COVID-19 pandemic and outbreak source tracing Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing Eurofins Discovery Supports Critical COVID-19 Drug Discovery Research with Products and Accelerated Drug Discovery Services Eurofins Technologies launches multiple new products for the serologic detection of antibodies in patients who have been exposed to COVID-19 Gold Standard Diagnostics COVID-19 Antibody Tests Now Available Viracor Eurofins Receives Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its SARS-CoV-2 RT-PCR laboratory-developed test (LDT) The National Kidney Registry and Viracor Eurofins Announce Coronavirus Antibody Testing for Donors and Recipients Eurofins Scientific Offers a full range of Testing services for Personal Protective Equipment (PPEs) and Medical Devices used in the fight against the COVID pandemic Eurofins’ U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing Announcing Labs@HOME, an In-Home Mobile Phlebotomy Blood Draw Service for Post-Transplant Patient Testing During COVID-19 Eurofins Technologies launches testing solutions for the detection of SARS-CoV-2 on environmental surfaces Eurofins Scientific Supports Healthcare Authorities in Europe, the U.S.A. and Brazil in their Fight against the COVID-19 Pandemic with Additional Testing Options and Fast Growing Capacity Eurofins Transplant Genomics and Viracor Will Partner to Offer Remote Sample Collection Options to Support Care for Kidney Transplant Recipients During COVID-19 Outbreak Diatherix Eurofins launches SARS-CoV-2 virus identification for the COVID-19 respiratory infection Eurofins Scientific Supports SARS-CoV-2 Analyses needs in the U.S.A. and in Europe with Multiple Testing Options Viracor Eurofins Launches Coronavirus SARS-CoV-2 RT-PCR Test with Same Day Results (12-18 Hours) Page d'accueil | Recherche | Carrière | Actualités | Contactez nous | Investisseurs Sitemap | Cookie Notice | Eurofins mondial Cookie Preferences © Eurofins France Last updated: mercredi 1 septembre 2021 About Cookies on This Site By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy Accept All Cookies Adjust Preferences